5 AI Healthcare Stocks To Buy

1. Schrodinger, Inc. (NASDAQ:SDGR)

Schrodinger, Inc. (NASDAQ:SDGR) is an AI-based drug discovery platform company. Schrodinger, Inc. (NASDAQ:SDGR)’s platform is used for drug discovery, atomic-scale simulation of chemical systems, modeling of antibodies and much more. Last year, the company received an approval from FDA to study its computer-designed therapy for non-Hodgkin lymphomas in an early-phase trial. Schrodinger’s AI-based platforms processed 8.2 billion potential compounds over a period of 10 months, identifying 78 that were synthesized and filtered through preclinical experiments to select the most promising candidate.

On January 9, Schrodinger, Inc. (NASDAQ:SDGR) and Bristol Myers Squibb (NYSE:BMY) amended their existing partnership to add a new discovery program in neurology. Schrödinger announced that it received an upfront payment for the new program. Schrodinger, Inc. (NASDAQ:SDGR) also has partnerships with Otsuka Pharmaceutical (OTCPK:OTSKF) (OTCPK:OTSKY) and the Japanese company’s unit Astex Pharmaceuticals.

Here is what Baron Growth Fund has to say about Schrödinger, Inc. in its Q4 2021 investor letter:

“Our Disruptive Growth investments are pursuing idiosyncratic opportunities across the entirety of the global economy. Schrodinger, Inc. is pushing the boundaries of drug development by pursuing novel diagnostics and therapeutics in areas including neurodegenerative disease and blood cancers.”

You can also take a peek at 10 Stocks to Buy According to Mark T. Gallogly’s Centerbridge Partners and 8 Stocks to Buy According to Alexander Captain’s Cat Rock Capital.